Replies to post #685072 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I do agree with you Cherry Tree, but I believe the approval in the UK will rapidly wrist any control the shorts attempt to have from them very quickly as I believe the demand for NWBO will be huge. I certainly could be wrong, it could be a longer struggle than just gaining our first approval, but I just don't see the shorts keeping the price below say $2 and I've got to believe that most of them would have margin calls that force them to take their losses in meeting their calls.

$5 or more, which should come in the future, is really a key as Institutional Ownership will greatly increase at that point. If the share price comes near $4 I believe the Institutions will begin buying in big time, some in the hope of driving the price over $5 before the end of the quarter, so they can hold, but even if they can't, they will increase the demand for the stock. Certainly there are Institutions that can invest below $5 and we'll be picking them up on a more permanent basis. I believe that once Institutional ownership grows the shorts will have little to no influence left at all.

Gary

[HappyLibrarian]

At this point, nothing would surprise me and like you, I am increasingly tempering my expectations for what MHRA will do for us and I am starting to look towards what the FDA approval will do for the SP or even just what bringing in tangible revenue that actually shows up in a meaningful way on our balance sheet will do.

For anyone who invested in Fall 2023 or onwards, the time spent invested, the price per share and the profit gained will work out well for them, even if MHRA isn't when we start getting golden eggs but obviously folks investing for the first time now will be better off than I ever will be or those who went before.

As you said, time will tell.